Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22 q22): An additional deletion in 9q is an adverse prognostic factor

Leukemia

Volumn 10, Issue 8, 1996, Pages 1288-1295

  Schoch, C ^a   Haase, D ^a,b   Haferlach, T ^c   Gudat, H ^a   Buchner T ^d   Freund, M ^e   Link, H ^f   Lengfelder, E ^g   Wandt, H ^h   Sauerland, M C ⁱ   Loffler H ^c   Fonatsch, C ^a,j  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e UNIVERSITY OF ROSTOCK   (Germany)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h KLINIKUM NÜRNBERG   (Germany)

ⁱ UNIVERSITY OF MÜNSTER   (Germany)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

more..

Author keywords

(t8; 21) (q22; q22); Acute myeloid leukemia; Cytogenetics; Secondary chromosome anomalies

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHILD; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 8; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SCHOOL CHILD; SEX CHROMOSOME; SEX DIFFERENCE; SURVIVAL TIME;

EID: 9344237642     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Second International Workshop on Chromosomes in Leukemia 1979. Cytogenetic, morphologie and clinical correlations in acute nonlymphocytic leukemia with t(8q-;21q+). Cancer Genet Cytogenet 1980; 2: 99-102.
2. Rowley JD, Alimena G, Garson M, Hagemeijer A, Mitelman F, Prigogina EL. A collaborative study of the relationship of the morphological type of acute nonlymphocytic leukemia with patient age and karyotype. Blood 1982; 59: 1013-1022.
3. Fourth International Workshop on Chromosomes in Leukemia 1982. Translocation (8;21)(q22;q22) in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1984; 11: 284-287.
4. Berger R, Flandrin G, Bernheim A, Le Coniat M, Vecchione D, Pacot A, Derré J, Daniel M-T, Valensi F, Sigaux F, Ochoa-Noguera ME. Cytogenetic studies on 519 consecutive de novo acute non-lymphocytic leukemias. Cancer Genet Cytogenet 1987; 29: 9-21.
5. Keating MJ, Cork A, Broch Y, Smith T, Waltes RS, McCredie KB, Trujillo J, Freireich EJ. Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leukemia Res 1987; 11: 119-133.
6. Fenaux P, Preudhomme C, Lay JL, Morel P, Beuscart R, Bauters F. Cytogenetics and their prognostic value in de novo actue myeloid leukaemia: a report on 283 cases. Br J Haematol 1989; 73: 61-67.
7. Schiffer CA, Lee EJ, Tomiyasu T, Wiernik PH, Testa JR. Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood 1989; 73: 263-270.
8. Marosi C, Köller U, Koller-Weber E, Schwarzinger I, Schneider B, Jäger U, Vahls P, Nowotny H, Pirc-Danoewinata H, Steger G, Kreiner G, Wagner B, Lechner K, Lutz D, Bettelheim P, Haas OA. Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML. Cancer Genet Cytogenet 1992; 61: 14-25.
9. Heim S, Mitelman F. Cytogenetic analysis in the diagnosis of acute leukemia. Cancer 1992; 70: 1701-1709.
10. Kaneko Y, Rowley JD, Maurer HS, Variakojis D, Moohr JW. Chromosome pattern in childhood acute nonlymphocytic leukemia (ANLL). Blood 1982; 60: 389-399.
11. Woods WG, Nesbit ME, Buckley J, Lampkin BC, McCreadie S, Kim TH, Piomelli S, Kersey JH, Feig S, Bernstein I, Hammond D for the Children's Cancer Study Group. Correlation of chromosome abnormalities with patient characteristics, histologie subtype and induction success with acute nonlymphocytic leukemia. J Clin Oncol 1985; 3: 3-11.
12. Schaison G, Leverger G, Berger R, Bernheim A, Daniel MZ, Flandrin G, Boiron M. Cytogenetic study (CS) of 130 childhood acute non lymphoblastic leukemia. Blood 1987; 70: 208a.
13. Hurwitz CA, Raimondi SC, Head D, Krance R, Mirro J, Kalwinsky DK, Ayers GD, Behm FG. Distinctive immunophenotypic features of t(8;21) (q22;q22) acute myeloblastic leukemia in children. Blood 1992; 80: 3182-3188.
14. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposal for the classification of the acute leukemias. Br J Haematol 1976; 33: 451-458.
15. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620-625.
16. Second MIC Cooperative Study Group. Morphologic, immunologie, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Cancer Genet Cytogenet 1988; 30: 1-15.
17. Groupe Francais de Cytogénétique Hématologique. Acute myelogenous leukemia with an 8;21 translocation. A report of 148 cases from the Groupe Francais de Cytogénétique Hématologique. Cancer Genet Cytogenet 1990; 44: 169-179.
18. Haferlach T, Bennett JM, Löffler H, Gassmann W, Andersen JW, Tuzuner N, Cassileth PA, Fonatsch C, Schlegelberger B, Becher R, Thiel E, Ludwig W-D, Sauerland MC, Heinecke A, Büchner T for the AML Cooperative Group and ECOG. Acute myeloid leukemia with translocation (8;21): Cytomorphology, dysplasia and prognostic factors in 41 cases. Leuk Lymphoma (in press).
19. Nucifora C, Rowley JD. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 1995; 86: 1-14.
20. Nucifora G, Rowley JD. The AML1 and ETO genes in acute myeloid leukemia with t(8;21). Leuk Lymphoma 1994; 14: 353-362.
21. Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 1993; 12: 2715-2721.
22. Erickson P, Gao J, Chang K-S, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley JD, Drabkin H. Identification of the breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fustion transcript, AML/ETO, with similarity to drosophila segmentation gene, runt. Blood 1992; 80: 1825-1831.
23. Zhang T, Million J, Tong J-H, Cao Q, Chen S-J, Berger R, Chen Z. AML-1 gene rearrangement and AML-1-ETO gene expression as molecular markers of acute myeloblastic leukemia with t(8;21). Leukemia 1994; 8: 729-734.
24. Weh HJ, Kuse R, Hoffmann R, Seeger D, Suciu S, Kabisch H, Ritter J. Hossfeld DK. Prognostic significance of chromosome analysis in de novo acute myeloid leukemia (AML). Blut 1988; 56: 19-26.
25. Yunis IJ, Lobell M, Arnesen MA, Oken MM, Mayer MG, Rydell RE, Brunning RD. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukemia. Br J Haematol 1988; 68: 189-194.
26. Trujillo JM, Cork A, Ahjearn MJ, Youness EL, McCredie KB. Hematologic and cytologie characterization of 8/21 translocation acute granulocytic leukemia. Blood 1979; 53: 695-706.
27. Tashiro S, Kyo T, Tanaka K, Oguma N, Hashimoto T, Dohy H, Kamada N. The prognostic value of cytogenetic analyses in patients with acute nonlymphocytic leukemia treated with the same intensive chemotherapy. Cancer 1992; 70: 2809-2815.
28. Palka G, Calabrese G, Fioritoni G, Stuppia L, Guanciali Franchi P, Marino M, Antonucci A, Spadano A, Torlontana G. Cytogenetic survey of 80 patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1992; 59: 45-50.
29. Swansbury GJ, Lawler SD, Alimena G, Arthur D, Berger R, Van Den Berghe H, Bloomfield CD, De la Chappelle A, Dewald G. Garson OM, Hagemeijer A, Mitelman F, Rowley JD, Sakurai M. Longterm survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer Genet Cytogenet 1994; 73: 1-7.
30. Haferlach T, Löffler H, Gaßmann W, Bennett JM, Ludwig W-D, Maschmeyer G, Thiel E, Nowrousian MR, Lang R, Kubica U, Weiss A, Lengfelder E, Koch P, Weh HJ, Tirier C, Sauerland MC, Heinecke A, Büchner T for the German AML Cooperative Group. Cytomorphological features and prognostic factors in 33 patients with acute myeloid leukemia (AML) and translocation (8;21). Blood 1994; 84: 308a (abstr.).
31. Swirsky DM, Li YS, Matthews JG, Flemans RJ, Rees JKH, Hayhoe GGJ. 8;21 translocation in acute granulocytic leukemia: cytological, cytochemical, and clinical features. Br J Haematol 1984; 56: 199-213.
32. Berger R, Bernheim A, Ochoa-Naguera ME, Daniel M-T, Valensi F, Sigaux F, Flandrin G, Boiron M. Prognostic significance of the chromosomal abnormalities in acute nonlymphocytic leukemia: a study of 343 patients. Cancer Genet Cytogenet 1987; 28: 293-299.
33. Heim S, Mitelman F. Secondary chromosome aberrations in the acute leukemias. Cancer Genet Cytogenet 1986; 22: 331-338.
34. Johansson B, Mertens F, Mitelman F. Secondary chromosomal abnormalities in acute leukemias. Leukemia 1994; 8: 953-962.
35. Stollmann B, Fonatsch Ch, Havers W. Persistent Epstein-Barr virus infection associated with monosomy 7 or chromosome 3 abnormality in childhood myeloproliterative disorders. Br J Haematol 1985; 60: 183-196.
36. Fonatsch Ch, Schaadt M, Kirchner H, Diehl V. A possible correlation between the degree of karyotype aberrations and the rate of sister chromatid exchanges in lymphoma lines. Int J Cancer 1980; 26: 749-756.
37. ISCN (1991). Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature. S Karger: Basel, 1991.
38. Kaplan EI, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Ass 1958; 53: 456-481.
39. Peto R, Pike MC, Armitage P, Breslow NE, Cox NR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1-39.
40. Büchner T, Urbanitz D, Hiddemann W, Rühl H, Ludwig W-D, Fischer J, Aul HC, Vaupel HA, Kuse R, Zeile G, Nowrousian MR, König HJ, Walter M, Wendt FC, Sodomann H, Hossfeld DK, von Paleske A, Löffler H, Gassmann W, Hellriegel K-P, Fülle HH, Lunscken Ch, Emmerich B, Pralle H, Pees HW, Pfreundschuh M, Bartels H, Koeppen K-M, Schwerdtfeger R, Donhuijsen-Ant R, Mainzer K, Bonfert B, Köppler H, Zuborn K-H, Ranft K, Thiel E, Heinecke A. Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AMD: two multicenter studies of the German AML Cooperative Group. J Clin Oncol 1985; 3: 1583-1589.
41. Link H, Hübner G, Meyer C, Freund M, Schneider B, Wandt H, Schönrock-Nabulsi P, Gramatzki M, Queisser W, Fackler-Schwalbe E, Löffler B, Raab M, Öhl S, Brack U, Gabius S, Ehninger G. Prospective comparative trial of postremission therapy in adult patients with acute myeloblastic leukemia: high dose cytosine arabinoside versus allogeneic and unpurged autologous bone marrow transplantation. Blood 1992; 80: 114a (Abstr.).
42. Creutzig U, Ritter J, Schellong G for the AML-BFM-Study Group. Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in the study AML-BFM-83 as compared with the study AML-BFM-78. Blood 1990; 75: 1932-1940.
43. Samuels BL, Larson RA, Le Beau MM, DaIy KM, Bitter MA, Vardiman JW, Barker CM, Rowley JD, Colomb HM. Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia 1988; 2: 79-83.
44. Bloomfield CD, Lawrence D, Arthur DC, Berg DT, Schiffer CA, Mayer RJ. Curative impact of intensification with high-dose cytarabin (HIDAC) in acute myelogenous leukemia (AML) varies by cytogenetic group. Blood 1994; 84: 111a (abstr.).
45. O'Brien S, Kantarjian HM, Keating M, Trujillo J, McCredie KB. Association of granulocytosis with poor prognosis in patients with acute myelogenous leukemia and translocation of chromosome 8 and 21. Blood 1988; 72: 218a (Abstr.).
46. Garson OM, Hagemeijer A, Sakurai M, Reeves BR, Swansbury GJ, Williams GJ, Alimena G, Arthur DC, Berger R, de la Chapelle A, Dewald GW, Mitelman F, Van Den Berghe H, Lawler SD, Rowley JD, Cytogenetic studies of 103 patients with acute myelogenous leukemia in relapse. Cancer Genet Cytogenet 1989; 40: 187-202.